ALAMEDA,
Calif., Jan. 21, 2025 /PRNewswire/ -- Penumbra,
Inc. (NYSE: PEN) today announced that it will host a conference
call to discuss financial results for the fourth quarter and full
year 2024 after market close on Tuesday,
February 18, 2025 at 4:30 PM Eastern
Time. A press release with fourth quarter and full year 2024
financial results will be issued after market close that day.
Webcast & Conference Call Information
The
conference call can be accessed live over the phone by dialing
(888) 596-4144 (conference id: 5872954), or the webcast can be
accessed on the "Events and Presentations" section under the
"Investors" tab of the company's website
at www.penumbrainc.com. The webcast will be available on
the company's website for at least two weeks following the
completion of the call.
About Penumbra
Penumbra, Inc., the world's leading
thrombectomy company, is focused on developing the most innovative
technologies for challenging medical conditions such as ischemic
stroke, venous thromboembolism such as pulmonary embolism, and
acute limb ischemia. Our broad portfolio, which includes computer
assisted vacuum thrombectomy (CAVT), centers on removing blood
clots from head-to-toe with speed, safety and simplicity. By
pioneering these innovations, we support healthcare providers,
hospitals and clinics in more than 100 countries, working to
improve patient outcomes and quality of life. For more information,
visit www.penumbrainc.com and connect on Instagram, LinkedIn and
X.
Investor Relations
Penumbra, Inc.
investors@penumbrainc.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-fourth-quarter-and-full-year-2024-earnings-release-and-conference-call-for-february-18-2025-302356557.html
SOURCE Penumbra, Inc.
